ITM and CNL Announce the Launch of Actineer, a New Joint Venture in the Global Production of Actinium-225
New company will advance Actinium-225 technologies, quickly secure supply, and construct a new production facility in Canada to produce industrial-scale quantities of rare medical isotope Garching / Munich, Germany and Chalk River, Ontario, Canada, October 18, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Canadian Nuclear Laboratories (CNL), which … Read more